DBV Technologies (France) Top Management

DBV Stock  EUR 0.80  0.01  1.23%   
DBV Technologies employs about 85 people. The company is managed by 25 executives with a total tenure of roughly 142 years, averaging almost 5.0 years of service per executive, having 3.4 employees per reported executive. Analysis of DBV Technologies' management performance can provide insight into the company performance.
MarieCatherine Therene  CEO
Deputy Chief Executive Officer and Responsible Pharmacist
Daniel Tasse  CEO
Chief Executive Officer, Director
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DBV Technologies SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade DBV Stock refer to our How to Trade DBV Stock guide.

DBV Technologies Management Team Effectiveness

The company has return on total asset (ROA) of (0.2178) % which means that it has lost $0.2178 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4299) %, meaning that it generated substantial loss on money invested by shareholders. DBV Technologies' management efficiency ratios could be used to measure how well DBV Technologies manages its routine affairs as well as how well it operates its assets and liabilities.

DBV Technologies Workforce Comparison

DBV Technologies SA is one of the top stocks in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 829. DBV Technologies retains roughly 85.0 in number of employees claiming about 10% of equities under Health Care industry.

DBV Technologies Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. DBV Technologies Price Series Summation is a cross summation of DBV Technologies price series and its benchmark/peer.

DBV Technologies Notable Stakeholders

A DBV Technologies stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as DBV Technologies often face trade-offs trying to please all of them. DBV Technologies' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting DBV Technologies' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
MarieCatherine ThereneDeputy Chief Executive Officer and Responsible PharmacistProfile
Daniel TasseChief Executive Officer, DirectorProfile
Michel RosenNon-Executive Independent Chairman of the BoardProfile
Ramzi BenamarChief Financial OfficerProfile
Sebastien RobitailleChief Financial OfficerProfile
Viviane MongesNon-Executive Independent DirectorProfile
Claire GirautNon-Executive Independent DirectorProfile
Daniel SolandNon-Executive Independent DirectorProfile
Julie ONeillNon-Executive DirectorProfile
Lucie MondouletDirector of ResearchProfile
Michael GollerNon-Executive DirectorProfile
Torbjorn BjerkeNon-Executive Independent DirectorProfile
Mailys FerrereNon-Executive DirectorProfile
Wence AgbotounouChief Clinical Trial OfficerProfile
Caroline DaniereChief Human Resource OfficerProfile
Adam SlatterChief Quality OfficerProfile
Daniel TassCEO DirectorProfile
Hugh SampsonChief Scientific OfficerProfile
Pascal WotlingChief Technical Operations OfficerProfile
Anne PollakHead RelationsProfile
Michele RobertsonChief Legal OfficerProfile
Joseph BeckerVP CommunicationsProfile
Sbastien RobitailleChief OfficerProfile
Pharis MohideenChief Medical OfficerProfile
Kevin TrappChief Commercial OfficerProfile

About DBV Technologies Management Performance

The success or failure of an entity such as DBV Technologies often depends on how effective the management is. DBV Technologies management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of DBV management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the DBV management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. DBV Technologies S.A. was founded in 2002 and is headquartered in Montrouge, France. DBV TECHNOLOGIES operates under Biotechnology classification in France and is traded on Paris Stock Exchange. It employs 97 people.
Please note, the presentation of DBV Technologies' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, DBV Technologies' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of DBV Technologies' management manipulating its earnings.

DBV Technologies Workforce Analysis

Traditionally, organizations such as DBV Technologies use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare DBV Technologies within its industry.

DBV Technologies Manpower Efficiency

Return on DBV Technologies Manpower

Revenue Per Employee67.2K
Revenue Per Executive228.3K
Net Loss Per Employee1.2M
Net Loss Per Executive3.9M
Working Capital Per Employee3.8M
Working Capital Per Executive12.8M

Complementary Tools for DBV Stock analysis

When running DBV Technologies' price analysis, check to measure DBV Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DBV Technologies is operating at the current time. Most of DBV Technologies' value examination focuses on studying past and present price action to predict the probability of DBV Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DBV Technologies' price. Additionally, you may evaluate how the addition of DBV Technologies to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes